2m 2m 2m 2m 2m 2m 2m
Pharmagreen Bio (PHBI)
OTC
$0.001$0.00 (0.00%)
Price as of Jun 03, 2026- $667,148.00Market Cap
- -9.09%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Pharmagreen Bio (PHBI)
$0.001$0.00 (0.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 55
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.0008
$0.001
$0.001
1-Year Range
$0.0007
$0.004
$0.001
Latest Close$0.001
Change
$0.00 (0.00%)
Volume785,198
Market Cap$667,148.00
Shares Outstanding691.3M
P/E (TTM)-1.21
Diluted EPS (TTM)-$0.0008
Enterprise Value$941,704.00
Information as of 06/03/2026
Company Profile
Pharmagreen Biotech Inc.
https://www.pharmagreen.ca$667,148.00
Market Cap
-$310,265.00
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
2987 Blackbear Court, Coquitlam, BC, Canada, V3E 3A2
702 803 9404Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.
Key Executives
- Peter Wojcik
- Terry Kwan
Current Ownership Distribution
- Other691.3M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)